JCCVS
Journal of Cardiology & Cardiovascular Surgery

Journal of Cardiology & Cardiovascular Surgery scientific, open-access, double-blind peer-reviewed journal covering a wide spectrum of topics in cardiology and cardiovascular surgery. This journal is indexed by indices that are considered international scientific journal indices (DRJI, ESJI, OAJI, etc.). According to the current Associate Professorship criteria, it is within the scope of International Article 1-d. Each article published in this journal corresponds to 5 points.

eISSN: 2980-1397
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Original Article
Determination of cardiovascular risks in adult individuals and assessment of the level of knowledge of cardiovascular risk factors
Abstract
Aims: In the last century, the negative effects of factors such as nutrition, intense work tempo and stress on cardiovascular health have been increasing. The importance of preventive health services is increasing and policies are being developed to increase quality. In Family Medicine practice, calculating the CVD risk that adult patients who do not have complaints about the cardiovascular system may experience in the coming years becomes important in this sense. Therefore, in this study, we aimed to calculate the ten-year risk of fatal cardiovascular events by SCORE risk scoring in apparently cardiovascularly healthy individuals presenting to a family medicine outpatient clinic and to plan treatment according to the results. We also aim to evaluate the awareness of CVD risk factors in these individuals by using the CARRF-KL Scale, whose reliability and efficacy have been shown in various previous studies.
Methods: 122 voluntary individuals between the ages of 40-80 were recruited to a family medicine polyclinic for any reason (43 males, 79 females). Participants' awareness was assessed by the cardiovascular disease risk awareness scale (KARRIF-BD) and the 10-year cardiovascular disease risk by the SCORE risk score.
Results: When the participants' SCORE risk averages were examined, 32.8% were low risk, 50.8% middle risk, 10.7% high risk and 5.7% very high risk group. When SBP levels according to the SCORE risk distribution were evaluated, in 7 patients with a very high risk distribution and the SBP value was higher than 130 mmHg, 2 of which were in the range of 130-139 mmHg, and 5 of them were above 140 mmHg. There was a statistically significant correlation between total cholesterol and LDL-C levels and SCORE risk score distribution of lipid profile distributions of participants (p<0.05). This relationship was not detected in HDL-C and TG levels. The mean scores of the men in the study group on the Karrif-BD scale were 24.83, while the women were 24.31 and there was no difference between the gender. When the KARRIF-BD scale mean scores were compared with the SCORE risk score distribution, no significant difference was found between the groups (F=1.026, p=0.384).
Conclusion: Our study suggests that SCORE risk assessment in cardiovascular disease is an easy assessment that can routinely be performed in family medicine outpatient clinics. It is possible that cardiovascular diseases can be detected and prevented in advance by the spread of clinical measures such as SCORE and risk measures such as KARRIF-BD

Keywords : Cardiovascular disease, risk factors, knowledge level, SCORE, KARRIF-BD

Download Article


1. Petersen S, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A.European Cardiovascular Statistics: 2005 edition. London: BritishHeart Foundation; 2005.
2. World Health Organization, Global status report on noncommunicablediseases 2014.
3. Toffler G, Psychosocial factors in coronary and cerebral vasculardisease, Uptodate, Jul 2016.
4. Dauchet L, Amouyel P, Dallongeville J. Fruit and vegetable consumptionand risk of stroke: a metaanalysis of cohort studies. Neurology2005;65(8):1193-1197.
5. Berry JD, Willis B, Gupta S, et al. Lifetime risks for cardiovasculardisease mortality by cardiorespiratory fitness levels measured at ages45, 55, and 65 years in men. The Cooper Center Longitudinal Study. JAm Coll Cardiol. 2011;57(15):1604-1610.
6. Piepoli MF, Hoes AW, Agewall S, et al.; Authors/Task Force Members.2016 European Guidelines on cardiovascular disease prevention inclinical practice: The Sixth Joint Task Force of the European Society ofCardiology and Other Societies on Cardiovascular Disease Preventionin Clinical Practice (constituted by representatives of 10 societies andby invited experts) Developed with the special contribution of theEuropean Association for Cardiovascular Prevention &amp; Rehabilitation(EACPR). Eur Heart J. 2016;37(29):2315-2381.
7. Conroy RM, Py&ouml;r&auml;l&auml; K, Fitzgerald AP, et al.; SCORE project group.Estimation of ten-year risk of fatal cardiovascular disease in Europe:the SCORE project. Eur Heart J. 2003;24(11):987-1003.
8. Arıkan İ, Metintaş S, Kalyoncu C, Yıldız Z. Kardiyovask&uuml;ler hastalıklarrisk fakt&ouml;rleri bilgi d&uuml;zeyi (KARRIF-BD) &Ouml;l&ccedil;eği&rsquo;nin ge&ccedil;erlik veg&uuml;venirliği. T&uuml;rk Kardiyoloji Derneği Araştırmaları 2009; 37(1): 35-40.
9. Mozaffarian D, Benjamin EJ, Go AS, et al.; American Heart AssociationStatistics Committee and Stroke Statistics Subcommittee. Heart diseaseand stroke statistics-2015 update: a report from the American HeartAssociation. Circulation 2015;131(4):e29-322.
10. O&rsquo;Rourke RA, Fuster Vi Alexander RW. Hurst Kalp Hastalıkları ElKitabı. 12. Baskı, İstanbul: Nobel Tıp Kitapevleri, 2012
11. Marso SP, Frutkin AD, Mehta SK, et al. Intravascular ultrasoundmeasures of coronary atherosclerosis are associated with theFramingham risk score: an analysis from a global IVUS registry.EuroIntervention 2009;5 (2):212-218.
12. Takeshita H, Shimada Y, Kobayashi Y, et al. Impact of body mass indexand Framingham risk score on coronary artery plaque. Osaka City MedJ 2008;54(1):31-39.
13. Rinehart S, Qian Z, Vazquez G, et al. Demonstration of the Glagovphenomenon in vivo by CT coronary angiography in subjects withelevatedFramingham risk: Int J Cardiovasc Imaging 2012;28(6):1589-1599.
14. Onat A, Şurdum-Avcı G, Şenocak M, &Ouml;rnek E, G&ouml;z&uuml;kara Y. Serumlipids and their interrelation in Turkish adults. J Epidemiol Comm Hlth1992; 46: 470-447.
15. Mahley RW, Palaoğlu KE, Atak Z, et al: Turkish Heart Study: Lipids,lipoproteins, and apolipoproteins. J Lipid Res 1995;36: 839-859.
16. Mahley RW, Mahley LL, Bersot TP, P&eacute;pin GM, Palaoğlu KE. TheTurkish lipid problem: low levels of high density lipoproteins. Turk JEndocr Metab 2002;1:1-12.
17. Hergenc G, Ozsullu T, Uzun A, Cetinalp P, Bayrak A, Maral H. KocaeliLipid Study. Low HDL in cardiovascular diseases. Atherosclerosis1999;146:S25.
18. Akoğlu L, &Ccedil;etinkaya K, &Ouml;ngel K. Efficiency of the Framingham, Cuoreand Score Scales in Primary Care. Smyrna Tıp Dergisi 2016,16(3): 11-18.
19. S&ouml;zmen K, Erg&ouml;r G, Belgin &Uuml;. Hipertansiyon sıklığı, farkındalığı,tedavi alma ve kan basıncı kontrol&uuml;n&uuml; etkileyen etmenler. Dicle TıpDergisi 2015;42(2), 199-207.
20. Arıcı M, Altun B, Erdem Y, et al. T&uuml;rk Hipertansiyon Prevalans&Ccedil;alişmasi. Journal Of Hypertension, 2005, 23.10: 1817-1823.
21. Lamm G (on behalf of WHO ERICA Research Group). The risk-map ofEurope. Ana Med 1989; 21:189.
22. Arıkan İ, Metintaş S, Kalyoncu C, Yıldız Z. Kardiyovask&uuml;ler hastalıklarrisk fakt&ouml;rleri bilgi d&uuml;zeyi (KARRİF-BD) &ouml;l&ccedil;eği&rsquo;nin ge&ccedil;erlik veg&uuml;venirliği. T&uuml;rk Kardiyol Dern Arş 2009;37(1):35-40.
23. Al Hamarneh YN, Crealey GE, McElnay JC. Coronary heart disease:health knowledge and behaviour. Int J Clin Pharm. 2011 Feb;33(1):111-123.
24. Jafary FH, Aslam F, Mahmud H, et al. Cardiovascular health knowledgeand behaviour in patient attendants at four tertiary care hospitals inPakistan-a cause for concern. BMC Public Health 2005; 5: 124-132.
25. Thanavaro JL. Barriers to coronary heart disease risk modification inwomen without prior history of coronary heart disease. J Am AcadNurse Pract. 2005;17(11):487-493.
26. Frijling B, Hulscher ME, van Leest LA, et al. Multifaceted support toimprove preventive cardiovascular care: a nationwide, controlled trialin general practice. Br J Gen Pract 2003;53: 934-941.
27. Scalzi LV, Ballou SP, Park JY, Redline S, Kirchner HL. Cardiovasculardisease risk awareness in systemic lupus erythematosus patients.Arthritis Rheum 2008;58(5):1458-1464.
28. Andsoy II, Tastan S, Iyig&uuml;n E, Kop LR. Knowledge and attitudestowards cardiovascular disease in a population of North WesternTurkey: A cross-sectional survey. Int J Caring Sci 2015; 8(1):115-124.
Article available in :
Volume 1, Issue 4, 2023
Page : 71-76
https://doi.org/10.51271/JCCVS-0019
Article Information
Received : 25 Kas 2023
Accepted : 19 Ara 2023
Published : 29 Ara 2023
Corresponding Author :

Şaban Keleşoğlu: Department of Cardiology, Faculty of Medicine, Erciyes University, Kayseri, Turkiye

[email protected]
Citation : Keleşoğlu Ş, Şafak ED, Keleşoğlu A. Determination of cardiovascular risks in adult individuals and assessment of the level of knowledge of cardiovascular risk factors. J Cardiol Cardiovasc Surg. 2023;1(4):71-76.

Read: 168
Cited: 0
Download : 58
_Footer